LSE:NCYT (Novacyt S.A.)

About NCYT

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: Lab21 Product segment is a developer, manufacturer, and distributor of a large range of protein-based infectious disease IVD products; IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.
  • Novacyt S.A. (LSE: NCYT) Latest News

    Investing Articles

    The Novacyt share price is up over 10,000% but I still think it’s a buy

    The price of Novacyt stock has soared, but I think its success in coronavirus tests has laid the groundwork for…

    Read more »

    Investing Articles

    Interested in the Novacyt share price? Read this first!

    The Novacyt share price has made early investors rich. Is the Covid-19 testing firm still a buy in 2020? Tom…

    Read more »

    Investing Articles

    Novacyt shares have doubled in a month. Should you keep buying?

    Strong demand for Covid-19 testing products has put a rocket under the Novacyt share price. But will pandemic success translate…

    Read more »

    Investing Articles

    Is the Novacyt share price too high? Here’s what you need to know

    The Novacyt share price is soaring after a strong H1 earnings announcement. But does that mean you should be buying?

    Read more »

    Investing Articles

    My best shares to buy now for UK investors during the crisis

    Many people want to find the best shares to buy now. But how should one do so? Anna Sokolidou thinks…

    Read more »

    Investing Articles

    Novacyt shares have soared! Are they a buy right now?

    Novacyt shares have rallied wildly! Are they still a buy right now? Anna Sokolidou tries to find out.

    Read more »

    Investing Articles

    The Novacyt share price has 20-bagged in 2020. Is there still time to buy?

    The Novacyt share price is flying as sales of Covid-19 tests soar. Alan Oscroft asks if the share price represents…

    Read more »

    Investing Articles

    The Novacyt share price has risen 2,500% this year! Is it worth adding to your ISA?

    The Novacyt share price is up! The biotech company is making Covid-19 testing kits for the UK government. But is…

    Read more »

    Investing Articles

    Novacyt share price surged 2,650% year-to-date! Can this wild ride continue?

    The Novacyt share price is experiencing volatility as it commits to increasing coronavirus test orders. Can it meet market expectations?

    Read more »

    Investing Articles

    Novacyt exploded higher, and I’m finding other strong-performing shares too

    One thing I’m sure about more than anything right now. Stock-picking is king. And I’m finding some great shares. Here’s…

    Read more »

    Investing Articles

    Can coronavirus test-maker Novacyt still make you rich?

    Coronavirus test-producer Novacyt (LON:NCYT) has likely made some savvy small-cap investors very wealthy. Could it still make money for new…

    Read more »

    Investing Articles

    Coronavirus test maker Novacyt soars 33% again. Here’s what I’d do now

    UK AIM-listed coronavirus test maker Novacyt says it has scored two major new deals worth millions in revenue and shares…

    Read more »